Helius Medical Technologies - Home


Call us: +1 877-564-0008


Stock Quote - HSDT

*Delayed quote courtesy of Google.

Board of Directors

President and CEO

Mr. Andreeff is the General Partner and Portfolio Manager of Maple Leaf Partners, L.P. and the President of Andreeff Equity Advisors, L.L.C. Mr. Andreeff has managed investment portfolios since 1996 for Andreeff Equity, L.P., Andreeff Overseas Ltd. and Clover Partners, LP. Prior to managing portfolios, Mr. Andreeff worked as an associate analyst at Furman Selz and Granite Capital International Group. Currently, Mr. Andreeff serves as a Director of TraceSecurity Inc., HDL Therapeutics, Inc. and Myocardial Solutions, Ltd.

Mr. Andreeff received his Master's degree in Economics from the University of Texas at Arlington in 1991 and Bachelor's degree in Economics from the University of Texas at Arlington in 1989.

Member, Board of Directors

Jeff is an accomplished senior executive and director of public and privately held companies with broad experience in the biopharmaceutical, medical device, semiconductor capital equipment and water filtration markets. Mr. Mathiesen has served as Director and Audit Committee Chair of Panbela Therapeutics, Inc. (Nasdaq: PBLA), a publicly traded biopharmaceutical company developing therapies for pancreatic diseases, since 2015, and was appointed Vice Chair and Lead Independent Director in March 2020. Mr. Mathiesen has also served as Director and Audit Committee Chair of NeuroOne Medical Technologies Corporation (Nasdaq: NMTC), a publicly traded medical technology company providing neuromodulation continuous EEG monitoring and treatment solutions for patients suffering from epilepsy and other nerve related disorders, since 2017, and Healthcare Triangle, Inc. (Nasdaq: HCTI), a leading provider of cloud and digital transformation, managed services and data analytics platform for healthcare and life sciences industry, since April 2022. He previously served as Director and Audit Committee Chair for eNeura, Inc., a privately held medical technology company providing therapy for both acute treatment and prevention of migraine, from 2018 to 2020. Mr. Mathiesen previously served as the CFO of Gemphire Therapeutics Inc., a publicly-held clinical-stage biopharmaceutical company developing therapies for patients with cardiometabolic disorders, and as CFO of Sunshine Heart, Inc., a publicly-held early-stage medical device company, both of which completed successful IPOs and follow-on equity offerings. Mr. Mathiesen has held executive and financial management positions with private and publicly traded companies dating back to 1987. He began his career at Deloitte & Touche LLP. Mr. Mathiesen received a B.S. in Accounting from the University of South Dakota and is also a Certified Public Accountant.

Member, Board of Directors, Member, Audit Committee 

Blane is a Partner at Talisman Capital Partners, a private investment partnership located in Columbus, Ohio.

Blane was the founder of inChord Communications, Inc., which he built into the largest independently-owned, healthcare communications company in the world. In 2005, inChord was acquired by Ventiv Health, the largest provider of outsourced sales and clinical services serving the pharmaceutical industry to create inVentiv Health. In 2008, Blane became CEO of the combined public company. Through organic growth and more than 20 acquisitions, inVentiv Health became the leading provider of outsourced product development and commercialization services to the global pharmaceutical and life sciences industries. inVentiv’s client roster consists of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies. In 2010, Mr. Walter led the successful $1.2 billion buyout of inVentiv Health by Thomas H. Lee Partners. Blane presently serves as Vice Chairman of inVentiv Health and also serves as Chairman of the Governor of Ohio’s Executive Workforce Board.

Prior to joining inChord, Mr. Walter worked as a Financial Analyst in New York City for Smith Barney in mergers and acquisitions specialty group. Blane actively pursues and over-sees investments in healthcare, information technology and marketing/professional services.

Mr. Walter graduated Summa Cum Laude with a Bachelor of Science degree in Marketing and Finance from Boston College.

Member, Board of Directors, Member, Audit Committee

Edward M. Straw is the founder and managing partner of Osprey Venture Partners—a firm that finds investment capital and assists with business development for startup entrepreneurs.  He is the retired President, Global Operations of The Estee Lauder Companies, and currently sits on the boards of the following companies: Academy Securities, Boston Consulting Group Federal, Odyssey Logistics, Helius Medical Technologies, and Lenitiv Scientific.   He is the Chairman of Odyssey Logistics.

During his ten-year tenure as Chairman of Odyssey, he has overseen the valuation of the company grow from $40M to $1.5B. 

As President, Global Operations for Estee Lauder, Mr. Straw led Lauder’s R&D, package engineering, acquisition, manufacturing, distribution, inventory management, and information systems organizations which supported 20 Estee Lauder Companies around the world.  In his five years at Estee Lauder, he is credited with directing significant improvements in their global supply chain and driving major stock price impacting savings to the bottom line.

Prior to joining the Estee Lauder Companies, he was Senior Vice President, Global Manufacturing and Supply Chain Management at the $40 billion Compaq Computer Corporation in Houston.  Before joining Compaq in late 1998, Mr. Straw was President of Miami-based Ryder Integrated Logistics—then the leading provider of third-party supply chain services in North America.   

Prior to joining the private sector, he had a distinguished career in the U.S. Navy, retiring as a three-star Admiral in 1996.  Vice Admiral Straw culminated his military service from 1992-1996 as the Director of the Defense Logistics Agency, the nation’s combat logistics support agency and primary provider of global supply chain material and services support for America’s armed forces.  He reported directly to the Under Secretary of Defense (AT&L), Dr. Paul Kaminski, and General Colin Powell, Chairman, Joint Chiefs of Staff, and was awarded two Defense Distinguished Service Medals for radical improvement to Army, Navy, Marine Corps and Air Force warfighting readiness. His implementation of just-in-time inventory management practices led to an estimated $10B cost savings to the services between 1992 and 2002. 

He also held numerous operational and policy leadership positions at the Navy’s major logistics commands—and was Navy’s lead for logistics planning and execution of material and ordnance support to Navy and Marine Corps forces during Operations Desert Shield and Desert Storm—while serving as the senior supply officer on the Chief of Naval Operations staff.  During this period, he also managed the Department of Defense Management Review which achieved $28B in savings between 1990 and 1997. 

Admiral Straw received multiple awards throughout his career, including Defense, Navy/Marine Corps and Air Force Distinguished Service Medals, Harvard University’s School of Public Administration and the Ford Foundation’s Innovations in American Government Award and the Society of Logistics Engineers’ Founders MedalHe is a Distinguished Graduate of the United States Naval Academy and recipient of the Navy Supply Corps’ Lifetime Achievement Award. 

Admiral Straw holds a Master of Business Administration degree from The George Washington University, a Bachelor of Science degree from the U.S. Naval Academy, and is a graduate of the National War College.

In addition to the boards listed above, he is a Trustee of the U.S. Naval Academy Foundation, a ten-year member of the Department of Defense Science Board, a venture affiliate with Boston Millennia Partners, a former pro bono advisor to the Secretary of Veterans Affairs, and has served on the Board of Directors of Eddie Bauer, MeadWestvaco, Panther Expedited Services, the Navy Federal Credit Union, the U.S. Chamber of Commerce, and the Boy Scouts of America.  He has also served in an advisory role to the IBM Federal Group,

Admiral Straw has worked with a group of patriots, since 2010, to regain disability/medical benefits for “Blue Water” Vietnam veterans suffering from Agent Orange related diseases, and in 2017 was selected by the Secretary of Veterans Affairs to the Commission for Veterans Benefits.  The House and Senate passed HR299 in May 2019, which restored disability and medical benefits to these “Blue Water” Veterans on January 1, 2020. He also takes great pride in assisting young men and women gain admission to the US Naval Academy.  Over the past 30 years, he has assisted approximately 75 young men and women graduate from Annapolis.

Admiral Straw has three daughters—Meg, Katie and Silvana.  Meg is a Lieutenant in the US Navy Supply Corps.  Daughter Katie is a recent Yale graduate and a Nurse Practitioner at the VA Medical Center in West Haven Ct.  Silvana is an executive with the Community Foundation of the National Capital Region and leads the Foundation’s highly recognized homeless housing initiatives.  He resides in Georgetown with his wife, Christine, an adjunct professor at Columbia University and Middlebury College.  

Member, Board of Directors, Member, Audit Committee, Member Nominating and Governance Committee

Ms. Perkins currently serves as a member of the Venture Mentoring Service at the University of Texas MD Anderson Cancer Center, providing guidance and perspective on commercialization-related topics that are important and relevant to the progression of various ventures. From 2017 to 2019, Ms. Perkins served as a consultant to LivaNova, PLC (NASDAQ: LIVN), a global medical technology company that designs, develops, manufactures and sells innovative therapeutic solutions in the fields of neuromodulation and cardiovascular disease. She previously spent 17 years at LivaNova and its affiliates in several roles, including serving as Vice President in the sleep apnea, new ventures space within the company from 2015 to 2017, and as Vice President of Marketing and New Business Development of Cyberonics, Inc. from 2011 to 2015.

Ms. Perkins received a B.S. in Medical Technology from Mississippi State University and an M.A. in Management from Central Michigan University

Member, Board of Directors

Mr. Buckman is currently the President of North America for LivaNova PLC. Prior to joining LivaNova, Mr. Buckman served as chief executive officer of Conventus Orthopaedics, a Minnesota-based company specializing in peri-articular bone fracture fixation, from September 2013 until March of 2017. Mr. Buckman was chief executive officer of Sentreheart, Inc., a medical technology company focused on closure of various anatomic structures, from February 2012 to September 2013. Previously, Mr. Buckman served as chief executive officer and chairman of Pathway Medical Technologies, Inc., a medical device company focused on treatment of peripheral arterial disease, from September 2008 to February 2012; as chief executive officer of Devax, Inc., a developer and manufacturer of drug eluting stents, from December 2006 to September 2008; as president of the cardiology division of St. Jude Medical, Inc., a publicly traded diversified medical products company, from August 2004 to December 2006; and as chairman of the board of directors and chief executive officer of ev3, LLC, a Minnesota-based medical device company focused on endovascular therapies that Mr. Buckman founded and developed into an $80 million business, from January 2001 to January 2004. Mr. Buckman has worked in the medical device industry for over 30 years, including 10 years at Scimed Life Systems, Inc. and Boston Scientific Corporation, a publicly traded medical device manufacturer, where he held several executive positions before becoming president of the cardiology division of Boston Scientific in January 2000. Mr. Buckman also currently serves as a director for NeuroOne, Inc. (Chairman), Ablative Solutions, Inc., ActivOrtho, Shoulder Innovations, and Miromatrix, Inc. (Chairman). He previously served as a director of Conventus Orthopaedics, Caisson Interventional LLC, Velocimed, Inc., where he was a co-founder, EndiCor, Inc., Microvena, Inc., Sunshine Heart, Inc., a publicly-held early-stage medical device company, NexGen Medical, and Micro Therapeutics, Inc. In addition to having raised in excess of $500M in private capital, the combined exit value of those companies in which Mr. Buckman has served as either CEO, Director or Co-Founder is approximately $2.8B. Mr. Buckman received a Master’s degree in Business Administration and Finance and a B.A. degree in Business Administration from Western Michigan University.